Highly expressed SLCO1B3 inhibits the occurrence and development of breast cancer and can be used as a clinical indicator of prognosis
Abstract The role of organic anion transporting polypeptide 1B3 (SLCO1B3) in breast cancer is still controversial. The clinical immunohistochemical results showed that a greater proportion of patients with negative lymph nodes, AJCC stage I, and histological grade 1 (P < 0.05) was positively corr...
Guardado en:
Autores principales: | Tiantian Tang, Guiying Wang, Sihua Liu, Zhaoxue Zhang, Chen Liu, Fang Li, Xudi Liu, Lingjiao Meng, Huichai Yang, Chunxiao Li, Meixiang Sang, Lianmei Zhao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2853113c773a4e87b44a88c8eca68b8a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Toward pharmacogenetic SLCO1B1‐guided dosing of methotrexate in arthritis using a murine Slco1b2 knockout model
por: Zachary L. Taylor, et al.
Publicado: (2021) -
Abiraterone induces SLCO1B3 expression in prostate cancer via microRNA-579-3p
por: Roberto H. Barbier, et al.
Publicado: (2021) -
SLCO3A1, A novel crohn's disease-associated gene, regulates nf-κB activity and associates with intestinal perforation.
por: Shu-Chen Wei, et al.
Publicado: (2014) -
A Cost–Consequence Analysis of Preemptive <i>SLCO1B1</i> Testing for Statin Myopathy Risk Compared to Usual Care
por: Charles A. Brunette, et al.
Publicado: (2021) -
A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients
por: Dingde Ye, et al.
Publicado: (2021)